{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:10:08Z","timestamp":1790197808645,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.fertnstert.2026.06.025","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:18:00Z","timestamp":1782170280000},"page":"230-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Possible therapeutic options for enhancing the number of oocytes in poor ovarian responders"],"prefix":"10.1016","volume":"126","author":[{"given":"Marcos","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Beccar Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kopcow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2026.06.025_bib1","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/humrep\/des131","article-title":"Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles","volume":"27","author":"Stoop","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib2","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib3","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.rbmo.2012.02.009","article-title":"Array CGH analysis shows that aneuploidy is not related to the number of embryos generated","volume":"24","author":"Ata","year":"2012","journal-title":"Reprod BioMed Online"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.fertnstert.2020.07.002","article-title":"Rate of true recurrent implantation failure is low: results of three successive frozen euploid single embryo transfers","volume":"115","author":"Pirtea","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/humrep\/deae040","article-title":"Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123 987 patients","volume":"39","author":"Gill","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/humrep\/dead177","article-title":"Human ovarian aging is characterized by oxidative damage and mitochondrial dysfunction","volume":"38","author":"Smits","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/humrep\/deae132","article-title":"Unveiling the role of chronic inflammation in ovarian aging: insights into mechanisms and clinical implications","volume":"39","author":"Zeng","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/humrep\/deaf049","article-title":"International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report for cycles conducted in 2017\u20132018","volume":"40","author":"Baker","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rbmo.2024.104413","article-title":"Assisted reproductive technologies in Latin America: the Latin American Registry, 2021","volume":"50","author":"Zegers-Hochschild","year":"2025","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib11","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib13","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/humrep\/deab050","article-title":"A large observational data study supporting the PROsPeR score classification in poor ovarian responders according to live birth outcome","volume":"36","author":"Lehert","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1472-6483(10)61110-8","article-title":"Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients","volume":"8","author":"Schr\u00f6der","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/humrep\/der479","article-title":"Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome","volume":"27","author":"Gallot","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3389\/fendo.2018.00589","article-title":"Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (FOI) index","volume":"9","author":"Alviggi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fendo.2019.00917","article-title":"Validation of ART calculator for predicting the number of metaphase II oocytes required for obtaining at least one euploid blastocyst for transfer in couples undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"10","author":"Esteves","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004379.pub3","article-title":"Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)","author":"Pandian","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib19","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, controlled trial comparing individualized versus conventional dosing","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0015-0282(99)00630-5","article-title":"Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques","volume":"73","author":"Surrey","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib21","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin-releasing-hormone-receptor antagonists","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib22","article-title":"ESHRE guideline on ovarian stimulation for IVF\/ICSI: 2025 update","year":"2025","journal-title":"Eur Soc Hum Reprod Embryol"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0015-0282(03)00544-2","article-title":"A new model for ovarian follicular development during the human menstrual cycle","volume":"80","author":"Baerwald","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2009.12.033","article-title":"An ongoing pregnancy from two waves of follicles developing during a long follicular phase of the same cycle","volume":"94","author":"Bentov","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib27","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.fertnstert.2015.02.020","article-title":"Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles","volume":"103","author":"Chen","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/dead038","article-title":"The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (DuoStim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF","volume":"38","author":"Massin","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/humrep\/dead276","article-title":"Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial","volume":"39","author":"Boudry","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/humrep\/dead002","article-title":"Routine double-ovarian-stimulation (DuoStim) in poor responders lacks rationale, evidence, and follow-up","volume":"38","author":"Tocci","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib32","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/humrep\/dead113","article-title":"DuoStim reduces time to pregnancy, minimizes treatment discontinuation, and is potentially cost-effective","volume":"38","author":"Garcia-Velasco","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib33","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s10815-024-03304-5","article-title":"The impact of Duostim protocol on pregnancy outcomes in infertile patients: A meta-analysis comparing single and double conventional stimulation cycles","volume":"41","author":"Zeng","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib34","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/deae104","article-title":"Double versus single stimulation in young low prognosis patients followed by a fresh embryo transfer: a randomized controlled trial (DUOSTIM-fresh)","volume":"39","author":"Racca","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10815-024-03317-0","article-title":"A multicycle approach through DuoStim with a progestin-primed ovarian stimulation (PPOS) protocol: a valuable option in poor prognosis patients undergoing PGT-A","volume":"42","author":"Vaiarelli","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2026.105465","article-title":"Changing the narrative for poor-prognosis patients in IVF: unlocking success through a multicycle approach","volume":"52","author":"Vaiarelli","year":"2026","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2669","article-title":"Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women","volume":"18","author":"White","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib38","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/humrep\/deab106","article-title":"Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon?","volume":"36","author":"Atkinson","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib39","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00404-024-07442-0","article-title":"Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis","volume":"309","author":"Vahabi Dastjerdi","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib40","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/humrep\/deae038","article-title":"Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial","volume":"39","author":"Barrenetxea","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib41","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/humrep\/deae093","article-title":"Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial","volume":"39","author":"Herlihy","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib42","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.18632\/aging.204401","article-title":"Rapamycin improves the quality and developmental competence of in vitro matured oocytes in aged mice and humans","volume":"14","author":"Yang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/deae085","article-title":"Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model","volume":"39","author":"Tanaka","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/humrep\/dead255","article-title":"Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro","volume":"39","author":"Rosario","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib45","article-title":"Ribosome dysregulation and intervention in age-related infertility","volume":"6","author":"Li","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0035-1567826","article-title":"Autologous Germline Mitochondrial Energy Transfer (AUGMENT) in human assisted reproduction","volume":"33","author":"Woods","year":"2015","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/humrep\/deag020","article-title":"Revisiting the promise and pitfalls of mitochondrial replacement therapies","volume":"41","author":"Costa-Borges","year":"2026","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.06.025_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/GCO.0000000000000268","article-title":"Activation of dormant follicles: a new treatment for premature ovarian failure?","volume":"28","author":"Kawamura","year":"2016","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226005194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226005194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:53:20Z","timestamp":1790196800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028226005194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0015028226005194"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.06.025","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible therapeutic options for enhancing the number of oocytes in poor ovarian responders","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92026 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}